JICHI MEDICAL UNIVERSITY

Genetically Modified Mosquitoes Show Promise in Malaria Vaccine Delivery

5 months ago

• Researchers have engineered mosquitoes to deliver a weakened malaria parasite, potentially enhancing immunity against the disease. • A clinical trial showed that 89% of participants who received the GA2 vaccine via mosquito bites developed immunity to malaria. • The GA2 vaccine uses a modified parasite that replicates in the liver for a longer period, allowing the immune system more time to respond. • While promising, the mosquito-delivered vaccine requires further testing in larger studies to assess long-term efficacy and protection against different malaria strains.